Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
56 hedge funds and large institutions have $20.7M invested in Gritstone bio, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 31 closing their positions.
155% more call options, than puts
Call options by funds: $252K | Put options by funds: $99K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $24.2M → $20.7M (-$3.58M)
29% less funds holding
Funds holding: 79 → 56 (-23)
42% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 24
74% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.27M |
| 2 |
FCH
Freestone Capital Holdings
Seattle,
Washington
|
+$312K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$113K |
| 4 |
Two Sigma Investments
New York
|
+$74.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$37.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.14M |
| 2 |
AG
Artal Group
Luxembourg
|
-$1.87M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.11M |
| 4 |
Goldman Sachs
New York
|
-$717K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$659K |
GRTS Hedge Fund Activity: Q3 2024 in Review
56 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2024, worth a combined $20.7M — down 15% from $24.2M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of GRTS and 8 opened new positions — a net loss of 23 holders — while 24 trimmed existing stakes and 14 added.
The largest buyer was Morgan Stanley, adding an estimated $3.27M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $2.14M sold.
- 56 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2024, down from 79 in Q2 2024.
- Funds reported $20.7M of Gritstone bio, Inc. Common Stock stock for Q3 2024, down 15% quarter-over-quarter.
- 8 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2024 and 31 closed out, a net change of -23 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q3 2024 was Morgan Stanley, an estimated $3.27M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q3 2024 was Alyeska Investment Group, an estimated $2.14M sold.
Based on aggregated 13F filings for Q3 2024.